Tomas Philipson

University of Chicago, Chicago, IL 
Biostatistics Biology, Public Health, Medicine and Surgery, Pharmacology
"Tomas Philipson"
Cross-listing: PHTree


Sign in to add trainee
George H. Zanjani grad student 2000 Chicago
Anup Malani grad student 2003 Chicago
Anupam B. Jena grad student 2006 Chicago
Carolanne Dai grad student 2007 Chicago
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Philipson TJ, Kamal-Bahl S, Jena AB. (2017) Defining Value: The Need for a Longer, Broader View. Pharmacoeconomics
Basu A, Axelsen K, Grabowski DC, et al. (2016) Real-World Data: Responses to Zito and Doshi. Medical Care
Basu A, Axelsen K, Grabowski DC, et al. (2016) Real World Data: Policy Issues Regarding their Access and Use. Medical Care
Jena AB, Stevens W, Gonzalez YS, et al. (2016) The wider public health value of HCV treatment accrued by liver transplant recipients. The American Journal of Managed Care. 22: SP212-9
Lo AW, Philipson TJ, von Eschenbach AC. (2016) Health, Wealth, and the 21st Century Cures Act. Jama Oncology. 2: 17-8
Seabury SA, Goldman DP, Gupta CN, et al. (2016) Quantifying gains in the war on cancer due to improved treatment and earlier detection Forum For Health Economics and Policy. 19: 141-156
Stevens W, MacEwan JP, Philipson TJ. (2015) Smoking And Cancer Mortality: The Authors Reply. Health Affairs (Project Hope). 34: 1609
Eber MR, Goldman DP, Lakdawalla DN, et al. (2015) Clinical evidence inputs to comparative effectiveness research could impact the development of novel treatments. Journal of Comparative Effectiveness Research. 1-11
Stevens W, Philipson TJ, Khan ZM, et al. (2015) Cancer mortality reductions were greatest among countries where cancer care spending rose the most, 1995-2007. Health Affairs (Project Hope). 34: 562-70
Lakdawalla D, Shafrin J, Lucarelli C, et al. (2015) Quality-adjusted cost of care: a meaningful way to measure growth in innovation cost versus the value of health gains. Health Affairs (Project Hope). 34: 555-61
See more...